Indo US Bio-Tech Ltd

Indo US Bio-Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indo US Bio-Tech Ltd

₹ 91.2 1.73%
19 Jun - close price
indousagriseeds.com BSE: 541304 NSE: INDOUS
About

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

Key Points

Business Overview:[1]
IUBTL is involved in crop Research and Development through breeding, seed production, processing, packing, and marketing of hybrid and open pollinated varieties of agricultural crops

Website BSE NSE
  • Market Cap ₹ 183 Cr.
  • Current Price ₹ 91.2
  • High / Low ₹ 206 / 87.1
  • Stock P/E 13.9
  • Book Value ₹ 46.2
  • Dividend Yield 0.27 %
  • ROCE 14.5 %
  • ROE 15.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 20.8% CAGR over last 5 years
  • Debtor days have improved from 64.6 to 45.5 days.
  • Company's median sales growth is 20.7% of last 10 years

Cons

  • Promoter holding has decreased over last quarter: -1.88%
  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
18.11 19.14 15.81 22.11 15.77 24.72 22.17 23.56 33.38 30.77 30.85 22.80 26.02
15.02 16.15 13.21 17.88 14.79 21.03 17.05 18.02 28.80 25.30 26.69 18.65 22.79
Operating Profit 3.09 2.99 2.60 4.23 0.98 3.69 5.12 5.54 4.58 5.47 4.16 4.15 3.23
OPM % 17.06% 15.62% 16.45% 19.13% 6.21% 14.93% 23.09% 23.51% 13.72% 17.78% 13.48% 18.20% 12.41%
0.02 0.03 0.00 0.08 0.21 0.03 0.02 0.02 0.12 0.00 0.03 0.01 0.02
Interest 0.27 0.37 0.41 0.37 0.36 0.33 0.52 0.38 0.26 0.45 0.42 0.77 0.60
Depreciation 0.21 0.20 0.21 0.19 0.20 0.20 0.18 0.16 0.56 0.20 0.21 0.22 0.27
Profit before tax 2.63 2.45 1.98 3.75 0.63 3.19 4.44 5.02 3.88 4.82 3.56 3.17 2.38
Tax % -5.32% 3.27% 15.66% 1.87% 17.46% 0.63% 2.03% -0.80% 4.90% 2.49% 3.09% 5.36% 17.23%
2.77 2.37 1.67 3.68 0.52 3.17 4.36 5.05 3.68 4.70 3.45 3.00 1.97
EPS in Rs 1.38 1.18 0.83 1.84 0.26 1.58 2.17 2.52 1.84 2.34 1.72 1.50 0.98
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
20 19 24 29 35 40 39 49 61 73 104 110
19 19 23 27 32 36 34 42 51 62 85 93
Operating Profit 1 0 1 3 3 4 6 7 9 11 19 17
OPM % 3% 3% 5% 9% 10% 10% 14% 14% 15% 15% 18% 15%
0 0 0 0 0 -0 0 0 0 0 0 0
Interest 0 0 1 1 0 1 1 1 1 2 1 2
Depreciation 0 0 0 0 0 0 0 0 1 1 1 1
Profit before tax 0 0 1 2 3 3 4 5 7 9 17 14
Tax % -92% -50% 25% 29% 26% 12% -23% 5% 2% 6% 2% 6%
0 0 0 1 2 3 5 5 7 8 16 13
EPS in Rs 1.11 0.80 0.89 1.41 1.44 1.74 3.52 2.86 3.60 4.11 8.11 6.54
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 19%
5 Years: 23%
3 Years: 22%
TTM: 6%
Compounded Profit Growth
10 Years: 43%
5 Years: 21%
3 Years: 22%
TTM: -19%
Stock Price CAGR
10 Years: %
5 Years: 40%
3 Years: -7%
1 Year: -40%
Return on Equity
10 Years: 18%
5 Years: 17%
3 Years: 18%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1 1 1 3 5 6 6 9 10 20 20 20
Reserves 1 2 2 2 9 10 15 30 44 43 58 72
2 5 5 7 6 9 11 12 12 14 15 37
3 6 4 6 4 10 11 4 3 7 4 4
Total Liabilities 8 14 13 17 24 35 44 56 69 84 98 133
1 1 1 2 1 1 2 6 7 7 10 11
CWIP 0 0 0 0 1 1 2 2 1 4 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
7 13 11 16 21 32 39 48 61 74 88 121
Total Assets 8 14 13 17 24 35 44 56 69 84 98 133

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -1 -3 -1 0 3 1 2 1 -13
-0 0 -3 -1 -2 -5 -7 -3 -1 -2
0 1 6 2 1 2 6 1 -1 20
Net Cash Flow -0 0 0 0 -0 -0 0 1 -1 6
Free Cash Flow -0 -1 -4 -1 -2 -1 -1 -0 1 -15
CFO/OP 11% -16% -92% -20% 6% 47% 9% 23% 9% -71%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 25 107 76 112 94 193 229 152 148 95 53 45
Inventory Days 91 118 92 98 176 751
Days Payable 57 115 64 71 34 667
Cash Conversion Cycle 59 110 104 138 236 276 229 152 148 95 53 45
Working Capital Days 66 33 34 59 129 137 186 257 285 266 247 248
ROCE % 14% 7% 14% 28% 20% 17% 18% 16% 15% 14% 21% 14%

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Active Dealers and Distributors
Count

Log in to view insights

Please log in to see hidden values.

Login
Proposed/Installed Processing Capacity
kg/hour
Land under Seed Production
Hectares
Number of Farmers Associated
Count
Processing Capacity
MT per day
Germplasm Collection
Count
Product Portfolio (Varieties/SKUs)
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
70.17% 70.17% 70.17% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 68.29%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.18%
29.83% 29.83% 29.83% 29.83% 29.82% 29.83% 29.82% 29.83% 29.83% 29.83% 29.83% 31.53%
No. of Shareholders 2513181,2271,1661,1339712,8282,7803,1124,1304,7384,531

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP